Nuvalent director’s awards cashed out in GSK deal
SEC Form 4 FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP…
Nuvalent director tenders shares in $124 GSK buyout
SEC Form 4 FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP…
GSK Completes Nuvalent Tender Offer at $124 Per Share | NUVL SEC Filing
This Amendment No. 4 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
Nuvalent takeover: HSR waiting period cleared, $124 per share offer | GSK SEC Filing
This Amendment No. 3 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
GSK offers $124 per share to acquire Nuvalent | NUVL SEC Filing
This Amendment No. 2 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
GSK launches $124-per-share Nuvalent tender offer | GSK SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER…
GSK offers $124.00 cash per share for Nuvalent | NUVL SEC Filing
This Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto, this “Schedule TO”) is…
GSK offers $124.00 per share for Nuvalent | NUVL SEC Filing
This Amendment No. 1 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (together with any…
GSK Just Dropped $10.6 Billion on a Lung Cancer Bet
GSK Just Dropped $10.6 Billion on a Lung Cancer Bet – Moby THE GIST Our analysts just identified…